Omentin is a novel adipokine with insulin-sensitizing effects and is especially produced by visceral adipose tissue, where circulating levels are decreased in insulin-resistant conditions, such as obesity and diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.